1. Home
  2. IH vs IMA Comparison

IH vs IMA Comparison

Compare IH & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.18

Market Cap

60.0M

Sector

Real Estate

ML Signal

HOLD

IMA

ImageneBio Inc.

HOLD

Current Price

$4.84

Market Cap

66.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
IMA
Founded
1996
2019
Country
China
United States
Employees
558
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.0M
66.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IH
IMA
Price
$1.18
$4.84
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
11.3K
14.5K
Earning Date
03-31-2026
05-15-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$3.94
52 Week High
$3.09
$9.10

Technical Indicators

Market Signals
Indicator
IH
IMA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
IH
IMA

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Share on Social Networks: